Retatrutide Triple Receptor Mechanism: How GIP, GLP-1 and Glucagon Synergy Drives Metabolic Effects
Retatrutide activates three metabolic receptors in a single molecule. Phase 2 data shows -24.2% mean weight loss at 48 weeks, suggesting synergistic effects beyond dual agonists like tirzepatide.
Read article